T
Thomas A. Ciulla
Researcher at Indiana University
Publications - 227
Citations - 12265
Thomas A. Ciulla is an academic researcher from Indiana University. The author has contributed to research in topics: Macular degeneration & Visual acuity. The author has an hindex of 51, co-authored 211 publications receiving 10807 citations. Previous affiliations of Thomas A. Ciulla include Houston Methodist Hospital & Harvard University.
Papers
More filters
Journal ArticleDOI
Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
TL;DR: To implement new therapies effectively, more individuals will need to be screened for DR/DME at earlier stages-a process requiring both improved technology and interdisciplinary cooperation among physicians caring for patients with diabetes.
Journal ArticleDOI
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.
Lloyd Paul Aiello,Sven-Erik Bursell,Allen C. Clermont,Elia Duh,Hidehiro Ishii,Chikako Takagi,Fumi Mori,Thomas A. Ciulla,Kirk Ways,Michael R. Jirousek,Lois E.H. Smith,Lois E.H. Smith,George L. King,George L. King +13 more
TL;DR: It is demonstrated that intravitreal injection of VEGF rapidly activates protein kinase C in the retina at concentrations observed clinically, inducing membrane translocation of PKC isoforms α, βII, and δ and > threefold increases in retinal vasopermeability in vivo.
Journal ArticleDOI
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen,Syed Mahmood Shah,Syed Mahmood Shah,Afsheen Khwaja,Roomasa Channa,Elham Hatef,Diana V. Do,David S. Boyer,Jeffery S. Heier,Prema Abraham,Allen B. Thach,Eugene S. Lit,Bradley S. Foster,Erik Kruger,Pravin U. Dugel,Thomas S.K. Chang,Arup Das,Thomas A. Ciulla,John S. Pollack,Jennifer I. Lim,Dean Eliot,Peter A. Campochiaro +21 more
TL;DR: Intraocular injections of RBZ provided benefit for patients with DME for at least 2 years, and when combined with focal or grid laser treatments, the amount of residual edema was reduced, as were the frequency of injections needed to control edema.
Journal ArticleDOI
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.
TL;DR: A randomized clinical trial of a single injection of triamcinolone acetonide into the vitreous cavity of experimental eye to examine the effects of intravitreal injection on the visual and clinical course of exudative age-related macular degeneration.
Journal ArticleDOI
Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update
TL;DR: Current literature most strongly supports the use of preoperative povidone-iodine antisepsis in cataract surgery, according to a systematic literature review and evidence rating.